Denali Therapeutics, Inc. (DNLI)

17.08 +0.01 (+0.06%) USD  |  NASDAQ  |  Jan 09, 16:00
17.18 +0.10 (+0.59%) After-Hours: 06:21
More

Denali Therapeutics Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Enovis Corp. --
Masimo Corp. Upgrade
Novavax, Inc. Upgrade
Protalix Biotherapeutics, Inc. --
Twist Bioscience Corp. --